203 related articles for article (PubMed ID: 31364156)
21. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
22. Bayesian sample size re-estimation using power priors.
Brakenhoff TB; Roes K; Nikolakopoulos S
Stat Methods Med Res; 2019 Jun; 28(6):1664-1675. PubMed ID: 29717945
[TBL] [Abstract][Full Text] [Related]
23. Power priors based on multiple historical studies for binary outcomes.
Gravestock I; Held L
Biom J; 2019 Sep; 61(5):1201-1218. PubMed ID: 30325059
[TBL] [Abstract][Full Text] [Related]
24. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
25. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
[TBL] [Abstract][Full Text] [Related]
26. Predictively consistent prior effective sample sizes.
Neuenschwander B; Weber S; Schmidli H; O'Hagan A
Biometrics; 2020 Jun; 76(2):578-587. PubMed ID: 32142163
[TBL] [Abstract][Full Text] [Related]
27. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
29. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
30. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
Kaplan D; Chen J; Yavuz S; Lyu W
Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
[TBL] [Abstract][Full Text] [Related]
31. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
32. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
Bennett M; White S; Best N; Mander A
Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
[TBL] [Abstract][Full Text] [Related]
33. Bayesian sample size determination using commensurate priors to leverage preexperimental data.
Zheng H; Jaki T; Wason JMS
Biometrics; 2023 Jun; 79(2):669-683. PubMed ID: 35253201
[TBL] [Abstract][Full Text] [Related]
34. Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.
Zhan T; Zhang H; Hartford A; Mukhopadhyay S
J Biopharm Stat; 2020 Sep; 30(5):821-833. PubMed ID: 32297825
[TBL] [Abstract][Full Text] [Related]
35. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
Bi D; Liu M; Lin J; Liu R
Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
[TBL] [Abstract][Full Text] [Related]
36. Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.
Callegaro A; Galwey N; Abellan JJ
Biostatistics; 2023 Apr; 24(2):443-448. PubMed ID: 37057610
[TBL] [Abstract][Full Text] [Related]
37. Adaptive treatment allocation for comparative clinical studies with recurrent events data.
Gao J; Su PF; Hu F; Cheung SH
Biometrics; 2020 Mar; 76(1):183-196. PubMed ID: 31282997
[TBL] [Abstract][Full Text] [Related]
38. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
[TBL] [Abstract][Full Text] [Related]
39. On efficient posterior inference in normalized power prior Bayesian analysis.
Han Z; Zhang Q; Wang M; Ye K; Chen MH
Biom J; 2023 Jun; 65(5):e2200194. PubMed ID: 36960489
[TBL] [Abstract][Full Text] [Related]
40. A Method for Constructing Informative Priors for Bayesian Modeling of Occupational Hygiene Data.
Quick H; Huynh T; Ramachandran G
Ann Work Expo Health; 2017 Jan; 61(1):67-75. PubMed ID: 28395307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
